News
Emerging Market ETF (EMCS) Hits Fresh 52-Week High
For investors seeking momentum, the Xtrackers MSCI Emerging Markets Climate Selection ETF (EMCS) is probably on the radar now. The fund just hit a 52-week high and is up 48.3% from its 52-week low
Dayforce to Report Q3 Earnings: What's in Store for the Stock?
Dayforce DAY is scheduled to release third-quarter 2025 results on Oct. 29.For the to-be-reported quarter, DAY expects revenues to be between $476 million and $486 million. Excluding float, total
Is Build-A-Bear's Asset-Light Model the Key to Sustainable Growth?
Build-A-Bear Workshop, Inc.’s BBW asset-light strategy is emerging as a key driver of its growth momentum. The company’s partner-operated retail model is enabling rapid international expansion
Stride to Report Q1 Earnings: Time to Buy or Sell This School Stock?
Stride, Inc. LRN is scheduled to report its first-quarter fiscal 2026 results on Oct. 28, after market close.In the last reported quarter, the company’s adjusted earnings per share (EPS) and total
Why Procter & Gamble Remains a Buy-and-Hold Favorite
Procter & Gamble (NYSE: PG) is a good bet for long-term total returns because its stock price is near the low end of its historical P/E range, its yield is near the high end of its range, and
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
Revvity, Inc. RVTY reported third-quarter 2025 adjusted earnings per share (EPS) of $1.18, which beat the Zacks Consensus Estimate of $1.14 by 3.5%. The bottom line, however, declined 7.8% from the
Eni Q3 Earnings & Revenues Beat on Higher Hydrocarbon Production
Eni S.p.A E reported third-quarter 2025 adjusted earnings from continuing operations of 90 cents per American Depository Receipt, which beat the Zacks Consensus Estimate of 73 cents. The bottom line
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Vertex Pharmaceuticals (VRTX) reports results for the quarter ended September 2025. While this widely-known
Vertex (VERX) Earnings Expected to Grow: Should You Buy?
Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives
Transcat, Inc. (TRNS) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Transcat, Inc. (TRNS) reports results for the quarter ended September 2025. While this widely-known consensus
QuinStreet (QNST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects QuinStreet (QNST) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when TG Therapeutics (TGTX) reports results for the quarter ended September 2025. While this widely-known consensus
Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Krystal Biotech, Inc. (KRYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?
The market expects Palantir Technologies Inc. (PLTR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This
Palomar (PLMR) to Report Q3 Results: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Palomar (PLMR) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Helios Technologies (HLIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Helios Technologies (HLIO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hologic (HOLX) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX) reports results for the quarter ended September 2025. While this widely-known consensus
Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Halozyme Therapeutics (HALO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hims & Hers Health, Inc. (HIMS) reports results for the quarter ended September 2025. While this widely-known
Freshpet (FRPT) Reports Next Week: Wall Street Expects Earnings Growth
Freshpet (FRPT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Exact Sciences (EXAS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Diamondback Energy (FANG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known